Safety and efficacy of HSCT for systemic sclerosis across clinical trials.
Publication
, Journal Article
Keyes-Elstein, L; Brittain, E; Pinckney, A; Goldmuntz, EA; Sullivan, KM
Published in: Nat Rev Rheumatol
November 2020
Duke Scholars
Published In
Nat Rev Rheumatol
DOI
EISSN
1759-4804
Publication Date
November 2020
Volume
16
Issue
11
Start / End Page
661
Location
United States
Related Subject Headings
- Transplantation, Autologous
- Scleroderma, Systemic
- Humans
- Hematopoietic Stem Cell Transplantation
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Keyes-Elstein, L., Brittain, E., Pinckney, A., Goldmuntz, E. A., & Sullivan, K. M. (2020). Safety and efficacy of HSCT for systemic sclerosis across clinical trials. Nat Rev Rheumatol, 16(11), 661. https://doi.org/10.1038/s41584-020-0493-2
Keyes-Elstein, Lynette, Erica Brittain, Ashley Pinckney, Ellen A. Goldmuntz, and Keith M. Sullivan. “Safety and efficacy of HSCT for systemic sclerosis across clinical trials.” Nat Rev Rheumatol 16, no. 11 (November 2020): 661. https://doi.org/10.1038/s41584-020-0493-2.
Keyes-Elstein L, Brittain E, Pinckney A, Goldmuntz EA, Sullivan KM. Safety and efficacy of HSCT for systemic sclerosis across clinical trials. Nat Rev Rheumatol. 2020 Nov;16(11):661.
Keyes-Elstein, Lynette, et al. “Safety and efficacy of HSCT for systemic sclerosis across clinical trials.” Nat Rev Rheumatol, vol. 16, no. 11, Nov. 2020, p. 661. Pubmed, doi:10.1038/s41584-020-0493-2.
Keyes-Elstein L, Brittain E, Pinckney A, Goldmuntz EA, Sullivan KM. Safety and efficacy of HSCT for systemic sclerosis across clinical trials. Nat Rev Rheumatol. 2020 Nov;16(11):661.
Published In
Nat Rev Rheumatol
DOI
EISSN
1759-4804
Publication Date
November 2020
Volume
16
Issue
11
Start / End Page
661
Location
United States
Related Subject Headings
- Transplantation, Autologous
- Scleroderma, Systemic
- Humans
- Hematopoietic Stem Cell Transplantation
- 3202 Clinical sciences
- 1103 Clinical Sciences